Stephen Philip WILLIAMS

Total number of appointments 15

• Date of birth: October 1976

SHIRE GLOBAL FINANCE (05418960)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 2 October 2018
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED (02486738)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 15 August 2018
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

TAKEDA CORPORATE SERVICES LIMITED (11022500)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 19 October 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE EUROPE FINANCE (05193881)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 September 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE BIOTECH UK HOLDINGS LIMITED (10945403)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 4 September 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE HOLDINGS UK CANADA LIMITED (05965409)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 June 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SPARKLEFLAME LIMITED (03114531)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, England, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

THE ENDOCRINE CENTRE LIMITED (02603613)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

RYBAR LABORATORIES LIMITED (00366644)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

MONMOUTH PHARMACEUTICALS LIMITED (01809476)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

VIROPHARMA LIMITED (06246349)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 5 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE US INVESTMENTS (06275900)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 4 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE UK INVESTMENTS LIMITED (05542355)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, W2 6BD
• Role (Resigned): Director
• Appointed on: 4 April 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE HUMAN GENETIC THERAPIES LIMITED (04243270)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 31 March 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England

SHIRE HUMAN GENETIC THERAPIES UK LIMITED (04061406)

• Company status: Dissolved
• Correspondence address: 1 Kingdom Street, London, United Kingdom, W2 6BD
• Role (Resigned): Director
• Appointed on: 31 March 2017
• Resigned on: 8 February 2019
• Nationality: British
• Country of residence: England